Bar Harbor Wealth Management Abbott Laboratories Transaction History

Bar Harbor Wealth Management

  • $1.55 Billion
  • Q3 2024

A detailed history of Bar Harbor Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Bar Harbor Wealth Management holds 139,222 shares of ABT stock, worth $15.9 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
139,222
Previous 141,403 1.54%
Holding current value
$15.9 Million
Previous $14.7 Million 8.02%
% of portfolio
1.02%
Previous 0.99%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
SELL
$100.07 - $118.13 $218,252 - $257,641
-2,181 Reduced 1.54%
139,222 $15.9 Million
Q2 2024

Jul 17, 2024
SELL
$100.73 - $112.44 $116,343 - $129,868
-1,155 Reduced 0.81%
141,403 $14.7 Million
Q1 2024

Apr 23, 2024
BUY
$109.52 - $120.96 $22,999 - $25,401
210 Added 0.15%
142,558 $16.2 Million
Q4 2023

Jan 17, 2024
SELL
$90.19 - $110.4 $135,465 - $165,820
-1,502 Reduced 1.04%
142,348 $15.7 Million
Q3 2023

Nov 28, 2023
SELL
$95.53 - $114.62 $204,816 - $245,745
-2,144 Reduced 1.47%
143,850 $13.9 Million
Q2 2023

Aug 09, 2023
SELL
$100.78 - $112.29 $514,078 - $572,791
-5,101 Reduced 3.38%
145,994 $15.9 Million
Q1 2023

Apr 24, 2023
SELL
$96.86 - $114.01 $589,683 - $694,092
-6,088 Reduced 3.87%
151,095 $15.3 Million
Q4 2022

Jun 09, 2023
BUY
$95.06 - $111.52 $578,725 - $678,933
6,088 Added 4.03%
157,183 $17.3 Million
Q4 2022

Jan 19, 2023
SELL
$95.06 - $111.52 $366,171 - $429,575
-3,852 Reduced 2.39%
157,183 $17.3 Million
Q3 2022

Oct 24, 2022
SELL
$96.76 - $112.03 $178,715 - $206,919
-1,847 Reduced 1.13%
161,035 $15.6 Million
Q2 2022

Aug 12, 2022
BUY
$102.07 - $123.37 $470,950 - $569,229
4,614 Added 2.92%
162,882 $17.7 Million
Q1 2022

Apr 14, 2022
SELL
$114.02 - $139.04 $365,548 - $445,762
-3,206 Reduced 1.99%
158,268 $18.7 Million
Q4 2021

Jan 28, 2022
SELL
$115.53 - $141.46 $180,573 - $221,101
-1,563 Reduced 0.96%
161,474 $22.7 Million
Q3 2021

Nov 15, 2021
SELL
$116.66 - $129.06 $182,106 - $201,462
-1,561 Reduced 0.95%
163,037 $19.3 Million
Q2 2021

Aug 11, 2021
SELL
$105.79 - $124.53 $391,846 - $461,259
-3,704 Reduced 2.2%
164,598 $19.1 Million
Q1 2021

May 06, 2021
SELL
$108.84 - $128.23 $246,740 - $290,697
-2,267 Reduced 1.33%
168,302 $20.2 Million
Q4 2020

Feb 09, 2021
SELL
$105.0 - $114.42 $14,175 - $15,446
-135 Reduced 0.08%
170,569 $18.7 Million
Q3 2020

Nov 02, 2020
SELL
$91.64 - $111.29 $550,206 - $668,185
-6,004 Reduced 3.4%
170,704 $18.6 Million
Q2 2020

Aug 04, 2020
BUY
$76.57 - $98.0 $323,125 - $413,560
4,220 Added 2.45%
176,708 $16.2 Million
Q1 2020

May 14, 2020
BUY
$62.82 - $91.86 $81,289 - $118,866
1,294 Added 0.76%
172,488 $13.6 Million
Q4 2019

Feb 11, 2020
BUY
$78.51 - $87.4 $671,339 - $747,357
8,551 Added 5.26%
171,194 $14.9 Million
Q3 2019

Nov 07, 2019
BUY
$81.84 - $88.74 $30,853 - $33,454
377 Added 0.23%
162,643 $13.6 Million
Q2 2019

Aug 01, 2019
BUY
$72.88 - $85.0 $72,588 - $84,660
996 Added 0.62%
162,266 $13.6 Million
Q1 2019

May 10, 2019
BUY
$66.22 - $80.06 $140,121 - $169,406
2,116 Added 1.33%
161,270 $12.9 Million
Q4 2018

Feb 13, 2019
SELL
$65.56 - $74.27 $231,099 - $261,801
-3,525 Reduced 2.17%
159,154 $11.5 Million
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $83,248 - $100,429
-1,369 Reduced 0.83%
162,679 $11.9 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $135,289 - $149,319
-2,350 Reduced 1.41%
164,048 $10 Million
Q1 2018

Apr 06, 2018
SELL
$56.27 - $63.62 $142,250 - $160,831
-2,528 Reduced 1.5%
166,398 $9.97 Million
Q4 2017

Jan 17, 2018
SELL
$53.68 - $57.47 $149,981 - $160,571
-2,794 Reduced 1.63%
168,926 $9.64 Million
Q3 2017

Oct 11, 2017
BUY
$48.06 - $53.64 $8.25 Million - $9.21 Million
171,720
171,720 $9.16 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bar Harbor Wealth Management Portfolio

Follow Bar Harbor Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email